Zacks.com: Bull of the Day
Zacks.com: Bull of the Day
-
China Life Insurance (LFC)
China Life Insurance (<a is scheduled to release its FY08 financial results on March 26, 2009. 1H08 results were disappointing due to the stock market decline. <p> Despite growing competition as well as volatile capital market, China Life seems to be in a better position than its peers due …
-
Isis Pharmaceuticals (ISIS)
Isis Pharmaceuticals, Inc. (<a is a drug discovery and development company focused on the therapeutic target RNA and developing products from RNA-based technologies, such as "antisense." We believe that antisense technology represents an exciting and potentially revolutionary pl …
-
Celgene Corporation (CELG)
Celgene Corp. (<a is a fully integrated biotechnology company focused on discovery, development and commercialization of drugs in the area of cancer and immune/inflammatory diseases. <p> The acquisition of Pharmion brings three medically meaningful products -- Thalomid, Revlimid and Vidaza …
-
National Semiconductor (NSM)
National Semiconductor Corp. (<a is an OEM [original equipment manufacturer] of analog and mixed-signal integrated circuits. November quarter revenue fell short of consensus expectations on both the top and bottom lines. <p> Forward guidance is for a revenue decline of -30% in the next quar …
-
Indevus Pharmaceuticals (IDEV)
We are initiating coverage of Indevus Pharmaceuticals (<a with a Buy and a $6 price target. <P to our investment thesis on Indevus is the eventual approval of Nebido in late calendar 2009. Therefore, we are encouraged by the fact that management has come to an agreement with the FDA on the re …
-
Lion's Gate (LGF)
We are initiating coverage of Lion's Gate (<a with a Buy rating. <P ALIGN="left"> With a strong track record of producing critically acclaimed small and mid-budget specialty films, we think Lion s Gate is well positioned to increase market share as the big studios …
-
Cypress Biosciences (CYPB)
Cypress Biosciences (<a - With a data from a third positive phase III trial in fibromyalgia released in early December 2008, we are feeling confident that the FDA will approval Cypress Bioscience's and partner Forest Labs' milnacipran product during the first quarter of 2009. < …
-
Cypress Biosciences (CYPR)
Cypress Biosciences (<a - With a data from a third positive phase III trial in fibromyalgia released in early December 2008, we are feeling confident that the FDA will approval Cypress Bioscience's and partner Forest Labs' milnacipran product during the first quarter of 2009. < …
-
EnCana Corporation (ECA)
EnCana Corporation (<a - EnCana Corp., based in Calgary, Alberta, is a major oil and gas exploration and production (E&P) company. EnCana is the largest independent natural gas producer of North America, with volumes of 3.57 billion cubic feet per day (Bcf/d) in 2007. <p> EnCana remains …
-
Garmin Ltd. (GRMN)
Garmin Ltd. (<a - Garmin is an OEM [original equipment manufacturer] of GPS-based equipment. September quarter results were in-line with the consensus on both the top and bottom lines. All segments were up double-digits in 2007, and are expected to be up again in 2008. <p> We note that pric …
-
Burger King Holdings Inc. (BKC)
Burger King Holdings (<a has resumed unit growth after four years of negative or no growth, during which time it repurchased and/or closed more than 1,000 under-performing franchises while reinvigorating its brand. <p> In our opinion, BKC is poised to grow earnings at a high-teens CAGR [com …
-
Genentech, Inc. (DNA)
Genentech, Inc. (<a - Genentech is one of the world's largest biotechnology companies. We are reiterating our rating on Genentech at a Buy, and moving our target price to $95 per share. <p> We remind investors that we upgraded the name in February based on the "Accelerated …
-
AvalonBay Communities (AVB)
AvalonBay Communities, Inc. (<a - Headquartered in Alexandria, Virginia, AvalonBay Communities is a real estate investment trust (REIT) which primarily focuses on developing high-quality, multi-family apartment communities for higher-income clients in high barrier-to-entry regions of the U.S. As …
-
Procter & Gamble (PG)
The Procter & Gamble Company (<a - Procter & Gamble's management is committed to a growth strategy based on (1) driving volume through product innovation and increasing penetration into developing markets and (2) expanding profitability by focusing on higher margin categories. < …
-
MEMC Electronic Materials (WFR)
MEMC Electronic Materials (<a - produces the raw material wafers used by semiconductor manufacturers in the production of integrated circuits (ICs). <p> The decision to supply wafers to the solar industry is paying huge rewards as demand for polysilicon has raced ahead of supply. The Solar …
-
ViroPharma, Inc. (VPHM)
ViroPharma Incorporated (<a - ViroPharma posted very strong financial results for the third quarter. Vancocin sales blew away expectations, coming in at $65.9 million, up 29%. Vancocin continues to benefit from impending treatment guideline changes and ViroPharma's new specialty salesforc …
-
Einstein Noah Restaurant Group (BAGL)
Einstein Noah Restaurant Group (<a is suffering the effects of constrained consumer spending, reporting its first quarter of negative comps in four years. We expect comps to remain negative and weigh on earnings into 2H09 or longer, depending on the economy. Longer-term, however, we think BAGL is …
-
Phase Forward, Inc. (PFWD)
Phase Forward (<a provides the software and services to assist clients in improving the efficiency of their clinical trials. The company offers a suite of applications: InForm, Clintrial and Clintrace. <p> PFWD earlier reported Q3 revenue of $43.2 million, up 23% from a year ago and up 5.1% …
-
SABESP (SBS)
We are keeping our Buy recommendation on Companhia de Saneamento Basico do Estado de Sao Paulo, or SABESP. The company posted reasonably positive results for the third quarter of 2008, even though its operating margins decreased. <p> The short-term outlook remains positive, due to the Septembe …
-
Colgate-Palmolive Company (CL)
Colgate-Palmolive Company (<a - New York City-based Colgate-Palmolive Co. is a global consumer products company with a distribution network reaching more than 200 countries. The company has a stellar long-term growth record. Positive earning surprises along with savings from the company's …
Zacks.com: Bull of the Day
